ADDITIONAL DISCUSSIONS. From time to time ACLA and TWTI agree to discuss the possibility of cooperating with each other with respect to the combination of ACLA's proprietary eTag technology and TWTI's proprietary Invader technology for certain commercial applications including for applications in the Genotyping Field and for Diagnostic Procedures. Notwithstanding the foregoing, neither Party shall have any liability arising out of or with respect to this Section 3.11.
Appears in 2 contracts
Sources: License Agreement (Aclara Biosciences Inc), License Agreement (Third Wave Technologies Inc /Wi)